List of quality statements

List of quality statements

Statement 1 People are made aware of the symptoms and signs of lung cancer through local coordinated public awareness campaigns that result in early presentation.

Statement 2 People with a chest X‑ray result suggesting lung cancer and people aged 40 and over with unexplained haemoptysis are offered an appointment to see a cancer specialist within 2 weeks.

Statement 3 This statement has been removed. For more details see update information.

Statement 4 People with known or suspected lung cancer have access to a named lung cancer clinical nurse specialist who they can contact between scheduled hospital visits.

Statement 5 People with lung cancer are offered a holistic needs assessment at each key stage of care that informs their care plan and the need for referral to specialist services.

Statement 6 People with lung cancer, following initial assessment and computed tomography (CT) scan, are offered investigations that give the most information about diagnosis and staging with the least risk of harm.

Statement 7 People with lung cancer have adequate tissue samples taken in a suitable form to provide a complete pathological diagnosis including tumour typing and sub‑typing, and analysis of predictive markers.

Statement 8 This statement has been removed. For more details see update information.

Statement 9 People with lung cancer are offered assessment for multimodality treatment by a multidisciplinary team comprising all specialist core members.

Statement 10 People with non-small-cell lung cancer stage I–III and good performance status who are unable to undergo surgery are assessed for radiotherapy with curative intent by a clinical oncologist specialising in thoracic oncology.

Statement 11 People with lung cancer stage I–III who are offered radiotherapy with curative intent receive planned treatment techniques that optimise the dose to the tumour while minimising the risks of normal tissue damage.

Statement 12 People with stage IIIB or IV non‑small‑cell lung cancer are offered systemic therapy in accordance with NICE guidance, that is directed by histology, molecular markers and PD-L1 expression.

Statement 13 People with small‑cell lung cancer have treatment initiated within 2 weeks of the pathological diagnosis.

Statement 14 People with lung cancer are offered a specialist follow‑up appointment within 6 weeks of completing initial treatment and regular specialist follow‑up thereafter, which can include protocol‑led clinical nurse specialist follow‑up.

Statement 15 People with lung cancer have access to all appropriate palliative interventions delivered by expert clinicians and teams.

In addition, quality standards that should also be considered when commissioning and providing a lung cancer service are listed in related NICE quality standards.